Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Lung|July 12, 2024
Transcriptomic Expression of T2-Inflammation Genes in Peripheral Blood Mononuclear Cells and Longitudinal Clinical Outcomes in Asthma: Insights from the COREA StudyDuong Duc Pham, Eunsoon Shin, Jong Eun Lee, et al.
Pflugers Archiv : European Journal of Physiology|November 1, 2016
Cardiac inotropy, lusitropy, and Ca2+ handling with major metabolic substrates in rat heartZai Hao Zhao, Jae Boum Youm, Yue Wang, et al.
Plos One|March 2, 2016
Impaired Inactivation of L-Type Ca2+ Current as a Potential Mechanism for Variable Arrhythmogenic Liability of HERG K+ Channel Blocking DrugsJae Gon Kim, Dong Jun Sung, Hyun-ji Kim, et al.
Pflugers Archiv : European Journal of Physiology|May 24, 2017
Neuronal nitric oxide synthase modulation of intracellular Ca2+ handling overrides fatty acid potentiation of cardiac inotropy in hypertensive ratsChun Li Jin, Ming Zhe Yin, Jin Chul Paeng, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 20, 2025
Concurrent Blood Eosinophils and FeNO as Biological Therapy Indicators in Severe Asthma: Findings From the Precision Medicine Intervention in Severe Asthma StudyDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 17, 2023
Prospective direct comparison of biologic treatments for severe eosinophilic asthma: Findings from the PRISM studyDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 2, 2023
WITHDRAWN: Prospective direct comparison of biological treatments on severe eosinophilic asthma: Findings from the PRISM studyDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
Lung|January 22, 2024
Predictors of Early and Late Lung Function Improvement in Severe Eosinophilic Asthma on Type2-Biologics in the PRISM StudyDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
ERJ Open Research|August 28, 2025
Biomarkers of type 2 inflammation as predictors of response to biologics for severe eosinophilic asthmaDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
The World Allergy Organization Journal|December 6, 2024
Longitudinal multi-trajectory phenotypes of severe eosinophilic asthma on type 2 biologics treatmentDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
Pageof 7